Influence of Oxytocin on Neurophysiological Responses to Live Faces

Oxytocin Clinical Trial

Official title:

Influence of Oxytocin on Neurophysiological Responses to Direct and Averted Gaze

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03272321
• Other study ID #: SingleOT_EEG-SC_S56327
• Status: Completed
• Phase: Phase 1/Phase 2
• Start date: July 24, 2017
• Est. completion date: May 18, 2018

Study information

• Verified date: July 2019
• Source: KU Leuven
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Previous research has indicated that direct eye gaze compared to averted gaze, elicits a higher skin conductance response (SCR), and a more pronounced left frontal cortex activity than right frontal cortex activity (resulting in positive asymmetry scores). On a behavioral level, participants tend to look shorter at live faces with a direct gaze as compared to averted gaze (Akechi et al., 2013). Further, subjective evaluations showed that a direct gaze is rated more arousing and less pleasant than an averted gaze (Akechi et al., 2013; Hietanen, Leppänen, Peltola, Linna-aho, & Ruuhiala, 2008).

Importantly, oxytocin administration increases the number of fixations and to looking time towards the eye region during live social interaction. Further, oxytocin has been shown to influence SCR and heart rate variability. Therefore, it is conceivable that oxytocin will not only influence the gaze duration of the participant, but also the physiological and neurological responses elicited by direct eye gaze.

In this study, the investigators will investigate whether oxytocin modulates the behavioural (eye gaze and subjective ratings), neurological (EEG) and physiological (skin conductance, heart rate and respiration) responses elicited by direct gaze.

Description:

Previous research has indicated that direct eye gaze compared to averted gaze, elicits a higher skin conductance response (SCR), and a more pronounced left frontal cortex activity than right frontal cortex activity (resulting in positive asymmetry scores). On a behavioral level, participants tend to look shorter at live faces with a direct gaze as compared to averted gaze (Akechi et al., 2013). Further, subjective evaluations showed that a direct gaze is rated more arousing and less pleasant than an averted gaze (Akechi et al., 2013; Hietanen, Leppänen, Peltola, Linna-aho, & Ruuhiala, 2008).

Importantly, oxytocin administration increases the number of fixations and to looking time towards the eye region during live social interaction. Further, oxytocin has been shown to influence SCR and heart rate variability. Therefore, it is conceivable that oxytocin will not only influence the gaze duration of the participant, but also the physiological and neurological responses elicited by direct eye gaze.

In this randomized, placebo controlled, double blinded study, the investigators will investigate whether oxytocin modulates the behavioral and neurophysiological responses elicited by direct gaze. In order to do so, the investigators will measure behavioural (eye gaze and subjective feelings), physiological (skin conductance, blood volume pulse, and respiration) and neurological (EEG) responses during presentations of a live person's face with direct gaze and closed eyes, before and after oxytocin or placebo administration.

The investigators hypotheses that oxytocin attenuates the heightened SCR and pronounced EEG asymmetry during direct gaze. Further, they expect that oxytocin increases the number of fixations and duration of those fixations towards the eye region. Exploratory, the investigators will also investigate whether oxytocin administration influences respiration and the subjective reports on experience of live eye contact. Lastly (and also exploratory), they will explore whether certain personality traits (as measured by SAAM (state adult attachment measure) and SRS (social responsiveness scale)) influence the modulatory effect of oxytocin on neurological and behavioural responses.

Note that this study is part of a larger study in which the investigators also register several neurophysiological responses (blood volume pulse, respiration, heart rate, EEG, skin conductance) during rest before and after oxytocin or placebo administration.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 56
• Est. completion date: May 18, 2018
• Est. primary completion date: May 18, 2018
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Male
• Age group: 18 Years to 35 Years

Eligibility

Inclusion Criteria:

• right-handed

• male

• age between 18 and 35

• Normal or adjusted-to-normal vision (with lenses only)

• Dutch as mother tongue

Exclusion Criteria:

• not right-handed

• female

• age below 18 or above 35

• Need to wear glasses

• Dutch not as mother tongue

Related Conditions & MeSH terms

• Oxytocin

Intervention

Drug:
• Oxytocin
Syntocinon nasal spray
• Placebo
Placebo nasal spray

Locations

Country	Name	City	State
Belgium	KU Leuven	Leuven

Sponsors (2)

Lead Sponsor	Collaborator
KU Leuven	Research Foundation Flanders

Country where clinical trial is conducted

Belgium, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change in EEG asymmetry after oxytocin administration	The influence of oxytocin administration on EEG asymmetry	Average over several trials, baseline and 40 min after oxytocin or placebo administration
Primary	Change in skin conductance (type of electrodermal activity) response after oxytocin administration	The influence of oxytocin administration on skin conductance response	Average over several trials, baseline and 40 min after oxytocin or placebo administration
Secondary	Change in duration of fixations to face regions after oxytocin administration	The influence of oxytocin administration on gaze behavior (duration of fixation to upper and lower face regions)	Assesment over several trials, baseline and 40 min after oxytocin or placebo administration
Secondary	Change in number of fixations to face regions after oxytocin administration	The influence of oxytocin administration on gaze behavior (number of fixation to upper and lower face regions)	Assesment over several trials, baseline and 40 min after oxytocin or placebo administration